Spaulding Clinical Selects BioQT™ for use with the Spaulding IQ™ ECG System
Spaulding Clinical Selects BioQT™ for use with the Spaulding IQ™ ECG System and Phase 1 Clinical Pharmacology Unit
News
OBS Medical to Attend the CBI and ACT’s 6th CardioVascular Risk Assessment Summit, January 30-31, 20
OBS Medical will be demonstrating BioQT, the future for Automated QT Analysis at the Cardiovascular Risk Assessment Summit. For more information come and meet us on the booth to discover the benefits BioQT can bring to your drug development trials.
OBS Medical Announces Contract Agreement for BioQT
OBS Medical is pleased to announce that it has successfully signed an agreement with a leading Clinical Research Organisation to use BioQT for their Thorough QT analysis trials.
Top 5 CRO evaluates BioQT
A top 5 global Clinical Research Organisation has requested the opportunity to evaluate BioQT with the view to use for automated QT analysis requirements. This is based on a growing demand from the pharmaceutical industry that is recognising the benefits which can be gained from this technology.
World Leading Pharmaceutical Company Evaluates BioQT
BioQT is to be evaluated by leading global pharmaceutical company. Results to be released in 2012.